secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2021-07-26T23:59:59+00:00
Accession:  0001640334-21-001671
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience appoints Dr. Praveen Tyle to board of directors
---------------------------------------------------------------

- Appointed Dr. Praveen Tyle as independent director effective July 22, 2021.
- Tyle will serve on compensation, audit, and nominating committees.
- Receives $40,000 annual director fee plus $8,500 committee compensation.
- Granted options for 250,000 shares; 10% vested immediately, remainder over 2 years.
- Options fully vest upon change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000164033421001671/0001640334-21-001671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000164033421001671/skye_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-21-001671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer